{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T16:27:10Z","timestamp":1788798430297,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.urolonc.2016.05.013","type":"journal-article","created":{"date-parts":[[2016,9,17]],"date-time":"2016-09-17T17:32:54Z","timestamp":1474133574000},"page":"483.e17-483.e24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Prognostic significance of markers of systemic inflammatory response in patients with non\u2013muscle-invasive bladder cancer"],"prefix":"10.1016","volume":"34","author":[{"given":"Aur\u00e9lie","family":"Mbeutcha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte","family":"Rieken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Rink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evanguelos","family":"Xylinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Seitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Lucca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Roupr\u00eat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre I.","family":"Karakiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Klatte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2016.05.013_bib1","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.eururo.2012.07.033","article-title":"Epidemiology and risk factors of urothelial bladder cancer","volume":"63","author":"Burger","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2016.05.013_bib2","unstructured":"M Babjuk, A B\u00f6hle, M Burger, E Comp\u00e9rat, E Kaasinen, J Palou, et al. RS: members of the EA of U (EAU) GO. Guidelines on non-muscle-invasive bladder cancer (Ta, T1 and CIS). EAU Guidelines; n.d."},{"key":"10.1016\/j.urolonc.2016.05.013_bib3","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2016.05.013_bib4","doi-asserted-by":"crossref","DOI":"10.1007\/s00345-015-1554-z","article-title":"Histopathology and prognosis of de novo bladder tumors following solid organ transplantation","author":"Ederer","year":"2015","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2016.05.013_bib5","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.urolonc.2013.11.010","article-title":"Effect of ABO blood type on mortality in patients with urothelial carcinoma of the bladder treated with radical cystectomy","volume":"32","author":"Klatte","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2016.05.013_bib6","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.eururo.2015.06.015","article-title":"Carbonic anhydrase IX as a diagnostic urinary marker for urothelial bladder cancer","volume":"68","author":"De Martino","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2016.05.013_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.eururo.2015.01.032","article-title":"Prognostic and prediction tools in bladder cancer: a comprehensive review of the literature","author":"Kluth","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2016.05.013_bib8","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/j.juro.2009.07.016","article-title":"Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model","volume":"182","author":"Fernandez-Gomez","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2016.05.013_bib9","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1038\/bjc.2013.372","article-title":"Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder","volume":"109","author":"Xylinas","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urolonc.2016.05.013_bib10","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, Inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.urolonc.2016.05.013_bib11","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.urolonc.2016.05.013_bib12","doi-asserted-by":"crossref","first-page":"e92079","DOI":"10.1371\/journal.pone.0092079","article-title":"Prognostic role of NLR in urinary cancers: a meta-analysis","volume":"9","author":"Wei","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.urolonc.2016.05.013_bib13","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.juro.2013.06.082","article-title":"Prognostic impact of preoperative neutrophil-to-lymphocyte ratio in localized nonclear cell renal cell carcinoma","volume":"190","author":"De Martino","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2016.05.013_bib14","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1007\/s00345-015-1559-7","article-title":"Comparison of the prognostic value of pretreatment measurements of systemic inflammatory response in patients undergoing curative resection of clear cell renal cell carcinoma","volume":"33","author":"Lucca","year":"2015","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2016.05.013_bib15","doi-asserted-by":"crossref","first-page":"67.e1-7","DOI":"10.1016\/j.urolonc.2014.06.010","article-title":"Neutrophil-to-lymphocyte ratio predicts progression and recurrence of non-muscle-invasive bladder cancer","volume":"33","author":"Mano","year":"2015","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2016.05.013_bib16","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nrurol.2011.145","article-title":"C-reactive protein as a biomarker for urological cancers","volume":"8","author":"Saito","year":"2011","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.urolonc.2016.05.013_bib17","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.eururo.2011.12.055","article-title":"Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinoma","volume":"61","author":"Rink","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2016.05.013_bib18","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM","volume":"17","author":"Edge","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.urolonc.2016.05.013_bib19","series-title":"Histologic typing of urinary bladder tumors","author":"Mostofi","year":"1973"},{"key":"10.1016\/j.urolonc.2016.05.013_bib20","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1089\/end.2012.0606","article-title":"Preoperative neutrophil\/lymphocyte ratio predicts overall survival and extravesical disease in patients undergoing radical cystectomy","volume":"27","author":"Krane","year":"2013","journal-title":"J Endourol"},{"key":"10.1016\/j.urolonc.2016.05.013_bib21","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.urology.2011.11.070","article-title":"Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy","volume":"79","author":"Gondo","year":"2012","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2016.05.013_bib22","doi-asserted-by":"crossref","first-page":"E348","DOI":"10.1111\/bju.12067","article-title":"Validation of serum C-reactive protein (CRP) as an independent prognostic factor for disease-free survival in patients with localised renal cell carcinoma (RCC)","volume":"111","author":"De Martino","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2016.05.013_bib23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.suronc.2013.12.001","article-title":"A systematic review and meta-analysis on the impact of pre-operative neutrophil lymphocyte ratio on long term outcomes after curative intent resection of solid tumours","volume":"23","author":"Paramanathan","year":"2014","journal-title":"Surg Oncol"},{"key":"10.1016\/j.urolonc.2016.05.013_bib24","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.eururo.2014.02.042","article-title":"Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy","volume":"66","author":"Viers","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2016.05.013_bib25","first-page":"3438","article-title":"Autocrine growth of transitional cell carcinoma of the bladder induced by granulocyte-colony stimulating factor","volume":"55","author":"Tachibana","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2016.05.013_bib26","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1023\/B:AGEN.0000029415.62384.ba","article-title":"Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor","volume":"6","author":"Kusumanto","year":"2003","journal-title":"Angiogenesis"},{"key":"10.1016\/j.urolonc.2016.05.013_bib27","first-page":"63","article-title":"TNF-alpha, IL-6 and their soluble receptor serum levels and secretion by neutrophils in cancer patients","volume":"49","author":"Jab\u0142o\u0144ska","year":"2001","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1016\/j.urolonc.2016.05.013_bib28","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/ijc.10775","article-title":"Differential response of primary and metastatic melanomas to neutrophils attracted by IL-8","volume":"103","author":"Schaider","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urolonc.2016.05.013_bib29","first-page":"4295","article-title":"Analysis of peripheral blood lymphocyte subsets in patients with bladder carcinoma","author":"Soyg\u00fcr","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2016.05.013_bib30","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/01.mpa.0000188305.90290.50","article-title":"Decreased total lymphocyte counts in pancreatic cancer: an index of adverse outcome","volume":"32","author":"Fogar","year":"2006","journal-title":"Pancreas"},{"key":"10.1016\/j.urolonc.2016.05.013_bib31","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.urolonc.2014.05.009","article-title":"Impaired estimated glomerular filtration rate is a significant predictor for non-muscle-invasive bladder cancer recurrence and progression\u2014introducing a novel prognostic model for bladder cancer recurrence","volume":"32","author":"Rausch","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2016.05.013_bib32","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0022-5347(01)69072-4","article-title":"Superficial bladder carcinoma treated with bacillus Calmette-Guerin: progression-free and disease specific survival with minimum 10-year followup","volume":"167","author":"Davis","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2016.05.013_bib33","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.eururo.2011.09.026","article-title":"Markers predicting response to bacillus Calmette-Gu\u00e9rin immunotherapy in high-risk bladder cancer patients: a systematic review","volume":"61","author":"Zuiverloon","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2016.05.013_bib34","first-page":"4","article-title":"Cytokine panel for response to intravesical therapy (CyPRIT): nomogram of changes in urinary cytokine levels predicts patient response to bacillus Calmette-Gu\u00e9rin","author":"Kamat","year":"2015","journal-title":"Eur Urol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143916300655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143916300655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:08:44Z","timestamp":1761041324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143916300655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S1078143916300655"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2016.05.013","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic significance of markers of systemic inflammatory response in patients with non\u2013muscle-invasive bladder cancer","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2016.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}